Cytomegalovirus Infection and Disease in Lung Transplant Recipients

被引：0
作者：
Lynch, B. L. [1 ]
Ging, P. [2 ]
Ronayne, A. [3 ]
De Gascun, C. [3 ]
Kleinerova, J. [4 ]
Egan, J. J. [4 ]
Hannan, M. M. [1 ]
机构：
[1] Mater Misericordiae Univ Hosp, Clin Microbiol, Dublin 7, Ireland
[2] Mater Misericordiae Univ Hosp, Dept Pharm, Dublin 7, Ireland
[3] Natl Virus Reference Lab, Dublin 4, Ireland
[4] Mater Misericordiae Univ Hosp, Dept Resp & Transplant, Dublin 7, Ireland
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2019年 / 38卷 / 04期
关键词：
D O I：
10.1016/j.healun.2019.01.787
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
777
引用
收藏
页码：S312 / S312
页数：1
相关论文
共 50 条
[21]   Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovir [J].
Fellay, J ;
Venetz, JP ;
Aubert, JD ;
Seydoux, C ;
Pascual, M ;
Meylan, PRA .
TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) :949-951
[22]   Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovir [J].
Fellay, J ;
Venetz, JP ;
Pascual, M ;
Aubert, JD ;
Seydoux, C ;
Meylan, PR .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (07) :1781-1782
[23]   Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients [J].
Ljungman, P ;
Deliliers, GL ;
Platzbecker, U ;
Matthes-Martín, S ;
Bacigalupo, A ;
Einsele, H ;
Ullmann, J ;
Musso, M ;
Trenschel, R ;
Ribaud, P ;
Bornhäuser, M ;
Cesaro, S ;
Crooks, B ;
Dekker, A ;
Gratecos, N ;
Klingebiel, T ;
Tagliaferri, E ;
Ullmann, AJ ;
Wacker, P ;
Cordonnier, C .
BLOOD, 2001, 97 (02) :388-392
[24]   PROPHYLACTIC GANCICLOVIR PREVENTS CYTOMEGALOVIRUS DISEASE IN LUNG-TRANSPLANT RECIPIENTS [J].
FOX, J ;
EDIN, C ;
DOSLAND, E ;
PETTY, M ;
BOLMAN, RM ;
HERTZ, M .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04) :A600-A600
[25]   ASSOCIATION OF CORONARY ARTERY DISEASE IN CARDIAC TRANSPLANT RECIPIENTS WITH CYTOMEGALOVIRUS INFECTION [J].
MCDONALD, K ;
RECTOR, TS ;
BRAUNLIN, EA ;
KUBO, SH ;
OLIVARI, MT .
AMERICAN JOURNAL OF CARDIOLOGY, 1989, 64 (05) :359-362
[26]   A prospective assessment of valganciclovir for the treatment of cytomegalovirus infection and disease in transplant recipients [J].
Humar, A ;
Siegal, D ;
Moussa, G ;
Kumar, D .
JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (07) :1154-1157
[27]   Management Strategies for Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients [J].
Razonable, Raymund R. .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2013, 27 (02) :317-+
[28]   Preemptive treatment for the prevention of cytomegalovirus disease - In lung and heart transplant recipients [J].
Egan, JJ ;
Lomax, J ;
Barber, L ;
Lok, SS ;
Martyszczuk, R ;
Yonan, N ;
Fox, A ;
Deiraniya, AK ;
Turner, AJ ;
Woodcock, AA .
TRANSPLANTATION, 1998, 65 (05) :747-752
[29]   Assessment of Letermovir as Universal Prophylaxis for Cytomegalovirus Infection in Lung Transplant Recipients. [J].
Borges, L. F. ;
Sparkman, T. ;
Gutierrez, K. ;
Banbury, J. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 :988-988
[30]   Management of cytomegalovirus infection in lung transplant recipients: Evidence-based recommendations [J].
Zamora, MR ;
Davis, RD ;
Leonard, C .
TRANSPLANTATION, 2005, 80 (02) :157-163
12345